Moderate to severe asthma
Clinical trials for Moderate to severe asthma explained in plain language.
Never miss a new study
Get alerted when new Moderate to severe asthma trials appear
Sign up with your email to follow new studies for Moderate to severe asthma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a spinal implant tame Hard-to-Control asthma?
Disease control Recruiting nowThis study tests whether a device that stimulates the spinal cord — called pulmonary neuromodulation — can improve asthma control in adults with moderate to severe asthma that remains uncontrolled despite high-dose inhalers or biologic medications. Participants receive the implan…
Matched conditions: MODERATE TO SEVERE ASTHMA
Sponsor: Spiro Medical, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New asthma shot aims to help patients breathe easier
Disease control Recruiting nowThis Phase 2 trial tests an injectable drug called RC1416 in 195 adults with moderate to severe asthma that is not well controlled. Participants will receive either the drug or a placebo by injection. The study will measure changes in lung function and track asthma attacks over t…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase 2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New program helps doctors prescribe better asthma treatment
Disease control Recruiting nowThis study tests a program to help doctors at community health centers prescribe a recommended asthma treatment called SMART (Single Maintenance and Reliever Therapy). The program includes training, feedback, and educational tools for both doctors and patients. Researchers will m…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase 4 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis Phase 3 trial tests an injectable drug called CM326 in 230 adults with moderate to severe asthma. The goal is to see if it can reduce the number of severe asthma attacks over one year. Participants will receive either CM326 or a placebo, and researchers will also measure cha…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase 3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC